He is not a doctor, and nothing here is medical advice
Thyroid C-cell findings: Preclinical studies in rodents with GLP-1 receptor agonists have identified C-cell hyperplasia
Primary Cellular Pathways Triple Incretin Receptor Activation Metabolic Regulation GLP3 functions as a triple agonist simultaneously activating GLP-1R, GIPR, and GCGR with distinct potency profiles[1]
In some embodiments, the otoprotectant is a compound of Formula (VIII) having the structure of Formula (VIIIa): In some embodiments, the otoprotectant is a compound of Formula (IX): wherein: R 1 is C 6 -C 10 aryl or C 3 -C 9 heteroaryl, wherein C 6 -C 10 aryl and C 3 -C 9 heteroaryl are optionally substituted with one or more R 4
Developing and testing a new drug is expensive, and companies count on recouping their costs by having, in effect, a monopoly on the market for a new drug
Read more: AUTHORS: Xinrui Jiang, Qianru Sun, Yunxia Chen, Ning Su, Jiaxuan Fang, Zixin Song, Meng Li, Changtao Wang & Dongdong Wang Maneesh Paul